Provided by Tiger Fintech (Singapore) Pte. Ltd.

Lexicon Pharmaceuticals

0.5098
+0.00981.96%
Post-market: 0.51000.0002+0.04%19:59 EDT
Volume:2.67M
Turnover:1.36M
Market Cap:184.29M
PE:-0.81
High:0.5262
Open:0.5001
Low:0.4980
Close:0.5000
Loading ...

Company Profile

Company Name:
Lexicon Pharmaceuticals
Exchange:
NASDAQ
Establishment Date:
1995
Employees:
103
Office Location:
2445 Technology Forest Boulevard,11th Floor,The Woodlands,Texas,United States
Zip Code:
77381
Fax:
281 863 8088
Introduction:
Lexicon Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of pharmaceutical products. Its orally-delivered small molecule drug candidates under development comprise Sotagliflozin that completed Phase III clinical trials for the for the treatment of heart failure and type 1 diabetes; and LX9211, which is in Phase II clinical development for the treatment of neuropathic pain and LX2761, which is in Phase I clinical development for gastrointestinal tract. Lexicon Pharmaceuticals, Inc. has strategic collaboration and license agreements with Bristol-Myers Squibb Company and Genentech, Inc. The company was incorporated in 1995 and is headquartered in The Woodlands, Texas.

Directors

Name
Position
Lonnel Coats
Chief Executive Officer and Director
Raymond Debbane
Chairman of the Board
Alan S. Nies
Director
Christopher J. Sobecki
Director
Frank P. Palantoni
Director
Judith L. Swain
Director
Philippe J. Amouyal
Director
Robert J. Lefkowitz
Director
Samuel L. Barker
Director

Shareholders

Name
Position
Lonnel Coats
Chief Executive Officer and Director
Brian T. Crum
Senior Vice President and General Counsel
Craig B. Granowitz
Senior Vice President and Chief Medical Officer
Jeffrey L. Wade
President and Chief Financial Officer
Kenneth B. Kassler Taub
Senior Vice President, Regulatory and Quality Assurance
Alan J. Main
Executive Vice President, Innovation and Chemical Sciences
Kiernan A. Seth
Vice President and Chief Commercial Officer
Kristen L. Alexander
Vice President, Finance and Accounting
Wendy E. McDermott
Vice President, Human Resources